by Richard Daverman, PhD
October 5, 2013 -- Tianjin Tasly Pharma acquired a 45% stake in Henan New Century Pharmaceutical for 151 million RMB ($24.7 million). New Century is a TCM maker whose primary product is Xingnaojing injection, a treatment for stroke. The drug has a wide range of indications combined with minimal side effects. Xingnaojing injection is the second best-selling cerebral TCM product in China. Tasly’s portfolio already includes salvianolic acid injection, also a stroke treatment. More details....
Stock Symbol: (SHA: 600535)
Help employers find you! Check out all the jobs and post your resume.